Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Location status: Recruiting
NCT Number: NCT05784922
The goal of this clinical trial is to promote lung cancer screening (LCS) uptake among Hispanic current and former smokers. The main questions it aims to answer are:
* What barriers do current and former Hispanic smokers face in the identification and documentation of their smoking status? * How can digital delivery of an educational video promote LCS uptake among current and former Hispanic smokers?
Participants will receive an educational video about lung cancer screening and complete brief, self-reported surveys afterwards.
Interested in participating?
Request Info50 year–80 year
All sexes
Observational
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Lung cancer remains the leading cause of cancer-specific mortality in the US, and Hispanics experience worse lung cancer outcomes and die at higher rates due to advanced stage at presentation. Lung cancer screening (LCS) can save many lives through early lung cancer detection among Hispanic current and former smokers.
Still, without increasing efforts to improve smoking status disclosure and documentation and tailored interventions to promote LCS uptake among Hispanic current and former smokers, this underserved population will continue to demonstrate disparities in lung cancer survival. Based on prior research experience, Dr. Flores has adapted the NIMHD research framework by incorporating elements from Ford's evidence-based theoretical model to guide the following proposed study aims:
Impact: The successful completion of this research will serve as a foundation for developing novel interventions to overcome disparities and advance equity in lung cancer outcomes among Hispanics and other vulnerable populations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An educational video on lung cancer screening tailored to Hispanic current and former smokers.
Time frame: Year 3
Reach is defined as >20% of enrolled participants interacting with the digital delivery of the LCS educational video (i.e., partial or complete review of the LCS educational video).
Time frame: Year 3
Overall proportion of participants that click on the embedded link to the successfully digitally delivered LCS educational videos
Time frame: Year 3
Duration of viewing the LCS video (i.e., partial or complete)
Time frame: Year 4
Overall proportion of survey completion by participants.
Time frame: Year 5
Identify salient participant characteristics obtained from the EHR (e.g., smoking status) among those that interacted with the digital delivery modality.
Time frame: Year 5
Investigate attributes of the intervention to guide future research and development to create such an intervention (for future trials)
Contact information is provided by the study sponsor or research team.
Massachusetts General Hospital
Other
Health Opportunities and Promoters of Equitable Screening for Lung Cancer (HOPES for Lung Cancer)
Acronym: HOPES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06489678
Diagnosis, Disease
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT04577599
Behavior, Lung Cancer
Charlotte, North Carolina, United States
View Trial DetailsNCT07287085
Disease, Lung Cancer
Rochester, New York, United States
View Trial DetailsNCT07463300
Disease, Lung Cancer
Guangzhou, Guangdong, China
View Trial Details